Vietnam's Protein Expression Market Grows as Biopharmaceutical and Biotechnology Research Expands

Vietnam's developing biotechnology and biopharmaceutical industries are creating new opportunities for protein expression technologies as pharmaceutical companies, research institutes and laboratories increase investment in recombinant proteins, biologics and advanced life-science research.

While there is currently no independently published valuation for Vietnam's overall Protein Expression Market, regional market data and Vietnam's existing recombinant protein sector suggest the market could be worth approximately US$15–25 million in 2025, potentially reaching US$28–50 million by 2030.

These figures should be regarded as an indicative estimate rather than a published Vietnam-specific market valuation.

Protein expression is the process through which cells produce proteins, and laboratory protein-expression technologies allow scientists to manufacture specific proteins for research, diagnostics, drug discovery and therapeutic development.

The market encompasses a broad range of expression systems and technologies, including bacterial, mammalian, yeast, insect and cell-free expression systems, alongside the reagents, vectors, competent cells, instruments and specialist services needed to produce and purify proteins.

Biopharmaceutical development drives demand

One of the strongest drivers is the expanding use of recombinant proteins and biologic medicines.

Recombinant protein technologies are used to manufacture therapeutic proteins including antibodies, hormones, enzymes, cytokines and growth factors. They are also fundamental to vaccine development, diagnostic reagents and pharmaceutical research.

Vietnam already has a measurable market in this area. IMARC Group estimates the country's Recombinant Protein Market reached US$9.2 million in 2025 and will grow to US$20.0 million by 2034, representing an 8.75% CAGR. Government expenditure on biopharmaceutical infrastructure, biosimilar demand, technology transfer and pharmaceutical R&D are identified as important market drivers.

Vietnam-specific research from 6Wresearch similarly identifies applications spanning drug discovery and development, academic research, biotechnology research and biopharmaceutical production, with pharmaceutical companies, biotechnology businesses, universities and CROs among the principal end users.

Proteomics and drug discovery create further opportunities

Protein expression is closely connected with proteomics, where scientists study the structure, function and interaction of proteins within biological systems.

Researchers frequently need to produce specific proteins in sufficient quantities to study their behaviour, identify drug targets, develop antibodies or investigate disease pathways. As Vietnam expands its capabilities in genomics, proteomics and precision medicine, demand for sophisticated protein-production technologies is therefore likely to increase.

Protein detection and quantification represents another part of this ecosystem. Vietnam already has a dedicated market spanning ELISA, Western blotting, mass spectrometry and chromatography, serving drug discovery, cancer research and clinical diagnostics.

Biosimilars could accelerate adoption

Vietnam's developing biosimilars industry represents a particularly important opportunity.

Many biologic medicines are proteins manufactured inside living cells. Producing biosimilars therefore requires highly controlled protein-expression systems capable of delivering consistent molecular structure, biological activity and product quality.

Mammalian-cell expression is particularly important for complex therapeutic proteins and monoclonal antibodies, while bacterial and yeast systems can offer faster and more cost-effective production for less complex recombinant proteins.

As Vietnam seeks to expand domestic pharmaceutical production and reduce reliance on imported medicines, investment in these technologies could become increasingly important.

Asia-Pacific protein expression market approaches US$1.7 billion

The wider regional outlook reinforces the opportunity.

BCC Research estimates the Asia-Pacific Protein Expression Market at US$951.8 million in 2025, forecasting it to reach approximately US$1.70 billion by 2030, representing a 12.3% CAGR. BCC identifies lower manufacturing costs, skilled workforces and favourable regulatory environments as factors supporting expansion across Asia-Pacific.

Globally, BCC estimates the market will increase from US$4.7 billion in 2025 to US$7.9 billion by 2030, growing at 10.9% annually. Increasing biotechnology investment and demand for therapeutic proteins are major drivers.

Other research providers also forecast strong expansion, although their definitions and valuations differ. Grand View Research estimates the global market at approximately US$4.0 billion in 2025, reaching US$7.1 billion by 2033, and highlights growing demand for recombinant therapeutic proteins as a key growth driver.

New technologies transform protein production

Technology is also changing how proteins are produced.

Cell-free protein expression enables proteins to be synthesised without maintaining living cells, potentially accelerating experimentation and allowing scientists to work with proteins that can be difficult to manufacture using conventional systems.

Automation and high-throughput screening are allowing laboratories to test multiple expression conditions simultaneously, while artificial intelligence can increasingly assist with protein design, expression optimisation and prediction of protein structure and behaviour.

These developments are making protein expression faster and more scalable across pharmaceutical R&D and biotechnology.

For Vietnam, the commercial opportunity extends beyond protein manufacturers themselves. Growth creates demand for bioreactors, cell-culture technologies, laboratory automation, purification systems, chromatography, reagents, expression vectors, analytical instruments, bioinformatics and contract research services.

As Vietnam strengthens its biotechnology, pharmaceutical and biopharmaceutical capabilities, protein expression is likely to become an increasingly important enabling technology supporting drug discovery, biosimilars, vaccines, diagnostics, proteomics and precision medicine.

For laboratory technology manufacturers, biotechnology companies, pharmaceutical organisations and research service providers, Vietnam therefore represents an early-stage but potentially fast-growing market within Southeast Asia's expanding life-sciences ecosystem.

READ THE FULL INSIGHTS REPORT